Tag: GSK

FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine

GSK selects Target the Future grant recipient in innovation challenge supporting multiple myeloma community

GSK announces independent Consumer Healthcare company is to be called Haleon

Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 vaccine

GSK receives first regulatory approval for Duvroq in Japan

GSK to produce1 billion doses of pandemic vaccine adjuvant

GSK partners with Samsung Biologics to expand biopharmaceutical manufacturing

Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19

FDA grant approval for GSK’s Voltaren Arthritis Pain for over-the-counter use in the United States

CEPI and GSK announce new collaboration to strengthen the global effort to develop a vaccine for the coronavirus (2019-nCoV virus)

ViiV Healthcare announces exclusive licensing agreement with NIH to develop investigational bNAb N6LS for treatment & prevention of HIV-1